IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ligand Pharmaceuticals I

CUSIP: 53220KAC2 | 1 institutional holders

Quarters

Q2 2015Q1 2015Q4 2014Q3 2014Q2 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2015

Advent Capital Management4,330,000
0.0% of portfolio›$6.3K
StyleTurnoverLocationFiled
Advent Capital Management
4,330,000$6.3K0.0%Deep ValueMediumNew York, NY2015-07-24